Global Degarelix Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Table of Contents
1 Degarelix Market Overview
- 1.1 Product Overview and Scope of Degarelix
- 1.2 Classification of Degarelix by Types
- 1.2.1 Global Degarelix Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Degarelix Revenue Market Share by Types in 2018
- 1.2.3 120 mg per vial
- 1.2.4 80 mg per vial
- 1.3 Global Degarelix Market by Application
- 1.3.1 Global Degarelix Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 Hospital
- 1.3.3 Drug store
- 1.4 Global Degarelix Market by Regions
- 1.4.1 Global Degarelix Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Degarelix Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Degarelix Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Degarelix Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Degarelix Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Degarelix Status and Prospect (2014-2024)
- 1.5 Global Market Size of Degarelix (2014-2024)
2 Manufacturers Profiles
- 2.1 Ferring
- 2.1.1 Business Overview
- 2.1.2 Degarelix Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Ferring Degarelix Revenue, Gross Margin and Market Share (2017-2018)
3 Global Degarelix Market Competition, by Players
- 3.1 Global Degarelix Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Degarelix Players Market Share
- 3.2.2 Top 10 Degarelix Players Market Share
- 3.3 Market Competition Trend
4 Global Degarelix Market Size by Regions
- 4.1 Global Degarelix Revenue and Market Share by Regions
- 4.2 North America Degarelix Revenue and Growth Rate (2014-2019)
- 4.3 Europe Degarelix Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Degarelix Revenue and Growth Rate (2014-2019)
- 4.5 South America Degarelix Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Degarelix Revenue and Growth Rate (2014-2019)
5 North America Degarelix Revenue by Countries
- 5.1 North America Degarelix Revenue by Countries (2014-2019)
- 5.2 USA Degarelix Revenue and Growth Rate (2014-2019)
- 5.3 Canada Degarelix Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Degarelix Revenue and Growth Rate (2014-2019)
6 Europe Degarelix Revenue by Countries
- 6.1 Europe Degarelix Revenue by Countries (2014-2019)
- 6.2 Germany Degarelix Revenue and Growth Rate (2014-2019)
- 6.3 UK Degarelix Revenue and Growth Rate (2014-2019)
- 6.4 France Degarelix Revenue and Growth Rate (2014-2019)
- 6.5 Russia Degarelix Revenue and Growth Rate (2014-2019)
- 6.6 Italy Degarelix Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Degarelix Revenue by Countries
- 7.1 Asia-Pacific Degarelix Revenue by Countries (2014-2019)
- 7.2 China Degarelix Revenue and Growth Rate (2014-2019)
- 7.3 Japan Degarelix Revenue and Growth Rate (2014-2019)
- 7.4 Korea Degarelix Revenue and Growth Rate (2014-2019)
- 7.5 India Degarelix Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Degarelix Revenue and Growth Rate (2014-2019)
8 South America Degarelix Revenue by Countries
- 8.1 South America Degarelix Revenue by Countries (2014-2019)
- 8.2 Brazil Degarelix Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Degarelix Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Degarelix Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Degarelix by Countries
- 9.1 Middle East and Africa Degarelix Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Degarelix Revenue and Growth Rate (2014-2019)
- 9.3 UAE Degarelix Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Degarelix Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Degarelix Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Degarelix Revenue and Growth Rate (2014-2019)
10 Global Degarelix Market Segment by Type
- 10.1 Global Degarelix Revenue and Market Share by Type (2014-2019)
- 10.2 Global Degarelix Market Forecast by Type (2019-2024)
- 10.3 120 mg per vial Revenue Growth Rate (2014-2024)
- 10.4 80 mg per vial Revenue Growth Rate (2014-2024)
11 Global Degarelix Market Segment by Application
- 11.1 Global Degarelix Revenue Market Share by Application (2014-2019)
- 11.2 Degarelix Market Forecast by Application (2019-2024)
- 11.3 Hospital Revenue Growth (2014-2019)
- 11.4 Drug store Revenue Growth (2014-2019)
12 Global Degarelix Market Size Forecast (2019-2024)
- 12.1 Global Degarelix Market Size Forecast (2019-2024)
- 12.2 Global Degarelix Market Forecast by Regions (2019-2024)
- 12.3 North America Degarelix Revenue Market Forecast (2019-2024)
- 12.4 Europe Degarelix Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Degarelix Revenue Market Forecast (2019-2024)
- 12.6 South America Degarelix Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Degarelix Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Degarelix (INN) or degarelix acetate (USAN), sold under the brand name Firmagon among others, is a hormonal therapy used in the treatment of prostate cancer.
Scope of the Report:
The global Degarelix market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Degarelix.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Degarelix market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Degarelix market by product type and applications/end industries.
Market Segment by Companies, this report covers
Ferring
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
120 mg per vial
80 mg per vial
Market Segment by Applications, can be divided into
Hospital
Drug store